New Study Reveals What Stops Young Women Living With HIV From Accessing Contraception
Biotechnology

New Study Reveals What Stops Young Women Living With HIV From Accessing Contraception

Researchers in Kenya examine how upcoming long-acting HIV treatments could help integrate family planning and overcome persistent barriers.

By Robert Brown
Published:
Email this Article
New Study Reveals What Stops Young Women Living With HIV From Accessing Contraception
Photo by Reproductive Health Supplies Coalition on Unsplash

Adolescent girls and young women face major hurdles accessing family planning services in western Kenya, where social stigma and provider attitudes compound the dual challenges of HIV management and reproductive healthcare. A qualitative study published in PLOS Global Public Health explored how these obstacles intersect with upcoming treatment innovations.

What Did the Study Discover About Young People Living with HIV?

The research team conducted seven focus group discussions involving 58 participants, including adolescents, healthcare providers, health advocates, and policymakers. The study took place between November 2021 and April 2022 at Rafiki Clinic within Moi Teaching and Referral Hospital in Eldoret. The participants examined multi-level barriers across individual, interpersonal, health system, and policy environments.

At the individual level, adolescents reported strong preferences for discreet, low-maintenance contraceptive methods that avoid detection by family members or partners. Daily oral pills proved difficult due to privacy concerns and pill fatigue, whereas injectable contraceptives and implants were more popular despite persistent community myths about fertility and side effects.

How Do Provider Stigma and Policy Barriers Affect Care?

Health system evaluations revealed that judgmental attitudes from clinical staff often discourage young people from seeking reproductive health services. Participants noted that some healthcare workers scolded minors or perpetuated misconceptions about birth control. Consequently, many adolescents turned to pharmacies for supplies, even though retail shops cannot provide clinical methods such as intrauterine contraceptive devices or implants.

Policy frameworks present additional challenges. Although national guidelines support youth-friendly care, mandatory parental consent requirements create confusion for providers who must balance adolescent confidentiality with parental authority. Supply chain gaps, including stock-outs of essential contraceptives, further disrupt continuous care delivery.

Can Long-Acting Therapies Transform Reproductive Health Services?

The study highlights how the anticipated introduction of long-acting antiretroviral therapy offers a unique chance to integrate family planning directly into HIV care. Because long-acting HIV treatments require scheduled clinic injection visits rather than daily pills, they establish natural touchpoints for healthcare providers to co-deliver contraceptive services.

Interpersonal dynamics also shaped outcomes. While peer mentors successfully normalized contraceptive use and provided trustworthy guidance, parental skepticism and imbalanced male partner involvement frequently restricted reproductive autonomy. Investigators emphasize that successful integration requires comprehensive training for healthcare workers, structured peer education programs, and policy reforms that streamline youth-friendly service delivery.

The research was published in PLOS Global Public Health on November 10, 2026.

Fact Checked

This article has been fact checked for accuracy, with information verified against reputable sources. Learn more about us and our editorial process.

Last reviewed on .

Article history

  • Latest version

Reference(s)

  1. Hassan, Shukri Ahmed., et al. “Addressing barriers and facilitators to family planning uptake among adolescent girls and young women in the anticipated context of long-acting antiretroviral therapy (LA ART).” PLOS Global Public Health, vol. 6, no. 11, November 10, 2026, pp. e0007546 Public Library of Science (PLoS), doi: 10.1371/journal.pgph.0007546. <https://doi.org/10.1371/journal.pgph.0007546>.

Cite this page:

Brown, Robert. “New Study Reveals What Stops Young Women Living With HIV From Accessing Contraception.” BioScience. BioScience ISSN 2521-5760, 11 November 2026. <https://www.bioscience.com.pk/en/subject/biotechnology/addressing-barriers-and-facilitators-to-family-planning-uptake-among-adolescent-girls-and-young-women-in-the-anticipated-context-of-long-acting-antiretroviral-therapy-la-art>. Brown, R. (2026, November 11). “New Study Reveals What Stops Young Women Living With HIV From Accessing Contraception.” BioScience. ISSN 2521-5760. Retrieved November 11, 2026 from https://www.bioscience.com.pk/en/subject/biotechnology/addressing-barriers-and-facilitators-to-family-planning-uptake-among-adolescent-girls-and-young-women-in-the-anticipated-context-of-long-acting-antiretroviral-therapy-la-art Brown, Robert. “New Study Reveals What Stops Young Women Living With HIV From Accessing Contraception.” BioScience. ISSN 2521-5760. https://www.bioscience.com.pk/en/subject/biotechnology/addressing-barriers-and-facilitators-to-family-planning-uptake-among-adolescent-girls-and-young-women-in-the-anticipated-context-of-long-acting-antiretroviral-therapy-la-art (accessed November 11, 2026).
End of the article